Author | Terri Davidson, PharmD

Articles

Pharmacology, Pharmacokinetics, and Practical Applications of Bortezomib

December 01, 2004

ByRowena N. Schwartz, PharmD|Terri Davidson, PharmD

Bortezomib (PS-341, Velcade) is a novel, first-in-class proteasomeinhibitor with antitumor activity against a number of hematologic andnonhematologic malignancies.